Cellular & Molecular Immunology, Published online: 16 October 2026; doi:10.1038/s41423-026-01461-4 Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2
Bo Peng, Siying Sun, Lin Zhu, Shufen Zhong, Xixi Chen, Yaguang Zhang et al. Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2. // Cellular & Molecular Immunology. – 2026. – DOI: 10.1038/s41423-026-01461-4. – URL: https://www.nature.com/articles/s41423-026-01461-4
Bo Peng, Siying Sun, Lin Zhu, Shufen Zhong, Xixi Chen, Yaguang Zhang, Huacheng Yan, Yidan Sun, Jiajia Lv, Yuying Huang, Jianye Zhang, Bing Sun, Guochao Shi, & Wei Tang (2026). Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2. Cellular & Molecular Immunology. https://doi.org/10.1038/s41423-026-01461-4
Bo Peng, et al. “Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2.” Cellular & Molecular Immunology, 2026. doi:10.1038/s41423-026-01461-4.
@article{Peng2026,
title = {Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2},
author = {Peng, Bo and Sun, Siying and Zhu, Lin and Zhong, Shufen and Chen, Xixi and Zhang, Yaguang and Yan, Huacheng and Sun, Yidan and Lv, Jiajia and Huang, Yuying and Zhang, Jianye and Sun, Bing and Shi, Guochao and Tang, Wei},
journal = {Cellular \& Molecular Immunology},
year = {2026},
doi = {10.1038/s41423-026-01461-4},
url = {https://www.nature.com/articles/s41423-026-01461-4}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’